Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3041678	b-intem	— (—)	274	369	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

severe traumatic brain injury, does not include concussion

11.87

51.39

1.4

1.3

—

Exposure to unspecified factor

108

166

4.69

41.82

1.3

—

Bleeding

122

5.31

40.16

1.4

—

Intracranial trauma

6.32

36.31

1.5

1.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

6.73

36.26

1.5

1.3

—

Intracranial injury

123

5.31

34.08

1.5

1.4

—

Fracture of lumbar spine and pelvis

9.51

32.28

1.7

1.2

—

Fracture of rib(s), sternum and thoracic spine

7.25

32.14

1.5

1.4

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

11.07

30.18

1.2

1.3

—

Complications of procedures, not elsewhere classified

153

4.33

29.81

1.2

1.4

—

Complications of surgical and medical care, not elsewhere classified

162

3.98

29.43

1.2

1.4

—

Injuries to the thorax

5.52

28.36

1.6

1.3

—

Epilepsy

6.47

28.35

1.3

1.4

—

Focal epilepsy

9.45

27.91

1.2

1.4

—

Implicit bacterial Sepsis

6.73

26.83

1.3

1.4

—

Other septicaemia

6.81

26.12

1.3

1.4

—

Focal epilepsy, strict definition

9.11

24.69

1.2

1.3

—

Bacterial Sepsis

5.83

24.67

1.3

1.4

—

Implicit bacterial Sepsis

5.99

24.35

1.3

1.4

—

Fracture of skull and facial bones

8.23

24.34

1.4

1.5

—

Complications of medical and surgical care

150

4.05

23.42

1.2

1.4

—

Traumatic subdural haemorrhage

19.85

23.28

1.4

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

8.37

23.11

1.3

—

Septicaemia

5.87

23.01

1.3

1.4

—

Convulsions, not elsewhere classified

7.36

22.09

1.1

1.6

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

126

4.36

22.07

1.2

1.4

—

Explicit Sepsis

5.51

22.05

1.3

1.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

134

4.13

20.86

1.2

1.4

—

Injuries to the head

173

3.20

20.13

1.4

1.3

—

Implicit Sepsis

135

3.68

19.81

1.3

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

138

3.58

19.39

1.3

1.4

—

Other bacterial diseases

153

3.38

19.34

1.3

1.4

—

Implicit Sepsis

123

3.80

19.09

1.2

1.4

—

Diseases of liver

5.01

18.97

1.2

1.4

—

Heart failure, not strict

112

3.82

18.84

1.2

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

149

3.38

18.46

1.3

1.4

—

Fracture of shoulder and upper arm

5.07

18.27

1.4

1.3

—

Injury of other and unspecified intrathoracic organs

25.21

18.21

1.7

1.4

—

Tramadol

114

3.61

17.94

1.3

1.4

—

Transport accidents

4.57

17.48

1.4

1.3

—

Nontraumatic intracranial haemmorrhage

7.04

17.35

1.3

1.2

—

135

3.68

17.16

1.4

—

Oesophageal varices

31.84

17.05

1.2

1.4

—

Substance abuse, excluding more controls

115

3.86

17.00

1.5

1.3

—

136

3.63

16.97

1.4

—

Fracture of femur

5.87

16.81

1.6

1.2

—

General symptoms and signs

134

3.07

16.07

1.2

1.5

—

Sequelae of external causes of morbidity and mortality

5.36

15.86

1.1

1.3

—

Sequelae with surgical and medical care as external cause

6.36

15.80

1.1

1.2

—

Mental and behavioural disorders due to psychoactive substance use

144

3.48

15.62

1.4

—

Oxycodone

4.97

15.48

1.3

—

Anaemias

8.17

15.39

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

6.68

15.28

1.3

—

Substance use, excluding alcohol

6.68

15.28

1.5

1.4

—

Bacterial infection, other or unspecified

3.97

15.27

1.4

—

Injuries to the hip and thigh

3.98

14.96

1.5

1.4

—

Alcohol use disorder, Swedish definition

129

3.56

14.93

1.4

—

Substance abuse

142

3.44

14.90

1.5

1.4

—

Bacterial infection, other or unspecified

4.05

14.78

1.3

1.4

—

Sequelae of injuries, of poisoning and of other consequences of external causes

5.28

14.63

1.4

1.5

—

Unspecified fall

120

3.70

14.51

1.2

1.4

—

Other bacterial diseases

165

2.85

13.95

1.3

1.4

—

Malaise and fatigue

3.93

13.91

1.2

1.5

—

STROKE

3.76

13.86

1.3

1.4

—

Cerebrovascular diseases (FINNGEN)

5.15

13.84

1.3

1.4

—

Sequelae of injuries of head

23.93

13.78

1.5

1.6

—

Dental caries

4.66

13.43

1.2

1.3

—

Persons encountering health services for specific procedures and health care

178

2.66

13.00

1.3

1.4

—

Malignant neoplasm of brain, including Hilmo

16.82

12.98

1.4

—

Caries of dentine

4.87

12.81

1.3

1.4

—

Transplanted organ and tissue status

12.28

12.58

1.2

1.3

—

Injuries to the shoulder and upper arm

183

2.77

12.18

1.4

—

Fibrosis and cirrhosis of liver

15.93

12.13

1.4

1.2

—

Care involving use of rehabilitation procedures

135

3.20

12.03

1.3

1.4

—

Cirrhosis of liver, NAS

21.41

12.01

1.4

1.1

—

L04AD Calcineurin inhibitors

10.04

11.96

1.2

1.4

—

Any event in cancer register

143

2.76

11.76

1.3

1.4

—

Malignant neoplasm, wide definition for exclusion

133

2.82

11.68

1.3

1.4

—

Concussion

3.81

11.21

1.4

1.5

—

Cerebrovascular diseases

131

2.90

10.92

1.3

—

Renal tubulo-interstitial diseases

162

2.71

10.78

1.2

1.3

—

Alcoholic liver disease

10.57

10.75

1.2

1.5

—

Diffuse brain injury

28.22

10.73

1.8

1.2

—

Pain, not elsewhere classified

4.55

10.68

1.1

1.4

—

Implicit viral Sepsis

4.71

10.68

1.2

1.3

—

Focal brain injury

21.52

10.67

1.5

1.1

—

Mental and behavioural disorders due to alcohol

128

3.16

10.65

1.5

1.4

—

Pneumonia, organism unspecified

178

2.56

10.47

1.4

—

Any death

103

3.13

10.41

1.2

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

190

2.48

10.33

1.4

—

Syncope and collapse

3.67

10.22

1.4

1.5

—

Follow-up examination after treatment for conditions other than malignant neoplasms

3.90

10.20

1.3

—

Malignant neoplasm of eye, brain and central nervous system

14.66

10.00

1.3

1.5

—

Unspecified privation

9.12

9.99

1.5

1.3

—

Pneumonias (Asthma/COPD co-morbidities)

190

2.44

9.98

1.4

—

Other anaemias

3.69

9.94

1.1

1.4

—

145

2.59

9.83

1.4

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

145

2.59

9.83

1.4

—

Other and unspecified anaemias

3.67

9.57

1.1

1.3

—

All pneumoniae

193

2.39

9.57

1.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

188

2.42

9.49

1.2

1.4

—

Malignant neoplasm

130

2.64

9.49

1.3

1.4

—

Solid cancers, helper endpoint

127

2.65

9.39

1.3

1.4

—

Hepatic failure, not elsewhere classified

21.85

9.35

1.2

1.3

—

Medical observation and evaluation for suspected diseases and conditions

3.17

9.32

1.4

—

Falls/tendency to fall

139

2.45

9.15

1.4

1.3

—

Iron deficiency anaemia

3.48

8.96

1.2

1.3

—

Ascites

12.55

8.86

1.2

1.4

—

Nutritional anaemias

3.25

8.82

1.2

1.3

—

Other disorders of fluid, electrolyte and acid-base balance

4.01

8.67

1.3

—

Spinal stenosis

3.09

8.58

1.2

1.4

—

Fever of other and unknown origin

105

3.05

8.55

1.4

1.5

—

Stroke, including SAH

110

2.84

8.54

1.3

1.4

—

Other and unspecified mood [affective] disorders

20.06

8.46

1.5

—

Injuries to the neck

4.16

8.44

1.2

1.3

—

Influenza and pneumonia

194

2.26

8.42

1.4

1.3

—

Cardiovascular diseases (excluding rheumatic etc)

2.85

8.38

1.3

1.4

—

Aplastic and other anaemias

3.29

8.38

1.1

1.4

—

Other and unspecified iron deficiency

3.73

8.31

1.2

1.3

—

Alcohol dependence

3.90

8.13

1.3

1.4

—

Pain in limb

159

2.40

8.04

1.3

1.4

—

Exposure to other specified factors

203

2.40

8.03

1.3

1.4

—

Infections, IBD-co-morbidities

11.92

8.02

1.1

2.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3.44

8.00

1.3

1.4

—

Thrombocytopenia, unspecified

10.81

7.79

1.4

—

Purpura and other haemorrhagic conditions

6.94

7.75

1.3

—

Erysipelas

106

2.92

7.73

1.2

1.5

—

Open wound of head

112

2.93

7.69

1.4

—

Fracture of lower leg, including ankle

144

2.68

7.57

1.6

1.3

—

Opioids

133

2.34

7.53

1.3

1.4

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

13.39

7.38

1.4

1.0

—

All kidney diseases

192

2.21

7.34

1.2

1.4

—

Other fall from one level to another

4.00

7.32

1.8

1.2

—

Other heart diseases

3.27

7.30

1.3

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

120

2.82

7.27

1.5

1.4

—

Fall on same level

176

2.14

7.17

1.3

1.4

—

Dysphagia

4.05

7.06

1.2

1.4

—

Invasive ventilation

10.04

7.03

1.4

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

190

2.16

7.01

1.4

1.3

—

Renal failure

2.98

6.89

1.0

1.4

—

Brain meningioma, including Hilmo

13.82

6.89

1.3

1.5

—

Intracerebral haemorrhage

7.52

6.88

1.0

1.2

—

Acute alcohol intoxication, ICD10

3.96

6.88

1.5

1.4

—

Other diseases of the digestive system

3.44

6.82

1.3

1.2

—

Type of accident

3.25

6.81

1.4

—

Other external causes of accidental injury

2.56

6.72

1.2

1.4

—

Spondylosis

110

2.67

6.67

1.2

1.4

—

Examination and observation for other reasons

2.85

6.64

1.3

1.4

—

L04AA Selective immunosuppressants

3.71

6.62

1.2

1.4

—

6.41

6.62

1.2

1.3

—

Anxiety disorders, excluding more controls

136

2.34

6.61

1.2

1.3

—

Acute tubulo-interstitial nephritis

128

2.56

6.59

1.3

1.4

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

182

2.06

6.56

1.2

1.4

—

Alcohol use disorder, ICD-based

111

2.80

6.55

1.4

—

Localized swelling, mass and lump of skin and subcutaneous tissue

3.34

6.53

1.3

—

Mood disorders, excluding more controls

143

2.25

6.53

1.3

—

Bacterial pneumonia, not elsewhere classified

3.14

6.50

1.4

—

Other neurological diseases

145

2.39

6.46

1.2

1.4

—

Accidents

2.51

6.31

1.3

1.4

—

Other condition

5.50

6.28

1.3

1.2

—

Obstructive hydrocephalus

+∞

6.26

1.0

0.0

—

Any mental disorder

146

2.13

6.25

1.4

1.3

—

Cardiovascular diseases

2.65

6.22

1.4

—

Symptoms and signs involving the skin and subcutaneous tissue

176

2.34

6.17

1.4

1.3

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.96

6.09

1.3

—

Brain meningioma

12.56

6.08

1.3

1.5

—

Acute renal failure

3.75

6.07

1.0

1.3

—

Acute alcohol intoxication

3.59

6.02

1.5

1.4

—

Bacterial pneumoniae

2.98

5.99

1.4

1.5

—

GI-bleeding

3.24

5.98

1.3

1.2

—

Aneurysms, operations, SAH

5.53

5.98

1.6

1.2

—

Asthma-related pneumonia

3.15

5.98

1.4

1.2

—

Asthma, hospital admissions 3, pneumonia

3.15

5.98

1.4

1.2

—

Asthma-related pneumonia or sepsis

3.15

5.98

1.4

1.2

—

GASTRO-related operations

2.45

5.94

1.5

1.4

—

Any gastric operation

2.45

5.94

1.5

1.4

—

Subarachnoid haemorrhage

7.24

5.91

1.5

1.3

—

Nephropathy related operations

5.78

5.82

1.1

1.3

—

Injuries to the elbow and forearm

167

2.26

5.79

1.5

1.3

—

Fracture of neck

11.15

5.79

1.3

—

Other soft tissue disorders, not elsewhere classified

164

2.07

5.76

1.2

1.4

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.51

5.66

1.1

1.3

—

Other antidepressants

150

2.05

5.59

1.4

—

Neoplasms

107

2.28

5.57

1.3

1.5

—

Stroke, excluding SAH

103

2.48

5.53

1.3

1.4

—

Metabolic disorders

154

2.10

5.51

1.4

1.3

—

Other diseases of pleura

2.75

5.44

1.3

—

Cervical disc disorders

2.95

5.40

1.1

1.4

—

Overexertion and strenuous or repetitive movements

6.21

5.38

1.2

1.3

—

Heart failure and antihypertensive medication

3.35

5.37

1.0

1.3

—

Erysipelas

130

2.29

5.27

1.2

1.4

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

3.80

5.24

1.1

1.3

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

+∞

5.23

1.6

0.0

—

Chronic pancreatitis

5.40

5.21

1.1

1.3

—

ILD medications: immunosuppressive drugs

168

2.21

5.20

1.2

1.4

—

Neuromuscular dysfunction of bladder

7.35

5.14

1.1

1.3

—

Constipation

159

2.09

5.11

1.4

1.3

—

Heart failure,strict

2.62

5.09

1.1

1.4

—

Unspecified haematuria

2.67

5.08

1.3

—

Organic, including symptomatic, mental disorders

2.66

5.05

1.3

—

Speech therapy

3.17

5.03

1.6

1.3

—

Artificial opening status

10.04

5.02

1.3

1.0

—

Diseases of arteries, arterioles and capillaries

119

2.30

5.01

1.1

1.4

—

Hypo-osmolality and hyponatraemia

4.67

4.95

1.3

—

Other diseases of biliary tract

6.89

4.95

1.0

1.3

—

Other medical care

2.71

4.95

1.2

1.4

—

Bacterial pneumonia (organism specified)

2.65

4.94

1.4

—

Other obstetric conditions, not elsewhere classified

3.26

4.89

1.2

1.3

—

Non-ischemic cardiomyopathy

3.19

4.81

1.3

—

Spondylopathies

127

2.12

4.80

1.3

1.4

—

Hepatocellular carcinoma, including Hilmo

11.50

4.79

1.5

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2.98

4.78

1.6

1.3

—

Asthma, unspecified (mode), excluding more controls

2.47

4.76

1.4

1.3

—

Postpartum hemorraghe, parous women as controls

3.49

4.71

1.1

1.4

—

Disorders of gallbladder, biliary tract and pancreas

179

1.94

4.71

1.1

1.4

—

Acute bronchitis

2.61

4.70

1.0

1.4

—

Low back pain

157

2.06

4.68

1.2

1.4

—

Cardiomyopathy

4.67

1.1

1.6

—

Implicit viral Sepsis

4.67

1.1

1.2

—

Viral Sepsis

4.67

1.1

1.2

—

Postpartum hemorraghe, all women as controls

3.35

4.61

1.1

1.3

—

Hydrocephalus

8.20

4.56

1.2

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

2.97

4.54

1.3

1.2

—

Neurological diseases

121

2.04

4.54

1.3

1.4

—

Certain infectious and parasitic diseases

131

1.99

4.53

1.4

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

4.17

4.50

1.3

—

Benign neoplasm: Cerebral meninges

6.68

4.46

1.3

—

Neurological diseases, wide definition

3.48

4.44

1.4

1.6

—

Symptoms and signs involving the digestive system and abdomen

147

1.91

4.37

1.4

—

Psychiatric diseases

133

1.96

4.36

1.5

1.2

—

Liquid cancers, helper endpoint

2.86

4.36

1.2

1.4

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

7.52

4.35

1.7

1.5

—

Congenital malformations, deformations and chromosomal abnormalities

161

2.13

4.34

1.3

1.4

—

Other disorders of urethra and urinary system

124

2.15

4.34

1.2

1.3

—

Suicide or other Intentional self-harm

2.88

4.32

1.6

1.5

—

Diseases of the digestive system

106

2.44

4.31

1.3

—

Aortic aneurysm

3.35

4.31

1.1

1.5

—

Other acute lower respiratory infections

125

2.29

4.29

1.0

1.5

—

Benign neoplasm of meninges

6.26

4.29

1.3

—

Disorders of continuity of bone

6.26

4.29

1.3

1.4

—

Other heart diseases, wide

158

1.94

4.28

1.2

1.4

—

Fall on and from stairs and steps

2.95

4.27

1.2

1.3

—

Hernia of abdominal wall, postoperative

4.49

4.24

1.0

1.4

—

Pulmonary embolism

3.04

4.23

1.4

1.2

—

Persons encountering health services for examination and investigation

2.33

4.21

1.3

1.4

—

Mood [affective] disorders

202

1.83

4.19

1.3

—

Mood disorders

202

1.83

4.17

1.3

—

Fall on same level involving ice and snow

147

2.18

4.12

1.4

1.3

—

Alcohol abuse, main dg, excluding more controls

4.34

4.12

1.5

1.3

—

Pulmonary heart disease

2.98

4.11

1.4

1.2

—

Retention of urine

2.78

4.10

1.5

1.3

—

Female infertility, associated with anovulation

8.01

4.06

1.0

1.2

—

Hypertensive diseases (excluding secondary)

2.52

4.05

1.5

1.4

—

Postpartum haemorrhage

3.13

4.02

1.1

1.3

—

Venous thromboembolism

131

2.21

4.00

1.3

1.4

—

Asthma, unspecified (mode)

100

2.26

3.99

1.4

1.3

—

Other viral hepatitis

6.45

3.98

1.6

1.5

—

Postpartum haemorrhage due to retained placenta

5.56

3.97

1.1

1.6

—

Other gastritis (incl. Duodenitis)

3.02

3.95

1.4

1.2

—

Chronic gastritis

3.02

3.95

1.1

1.2

—

Sequelae of cerebrovascular disease

2.78

3.94

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.28

3.93

1.3

1.4

—

Headache

118

2.17

3.92

1.2

1.4

—

Other diseases of intestines

184

1.79

3.91

1.3

1.4

—

Dialysis, with operation codes

4.07

3.89

1.1

1.2

—

Superficial injury of head

3.79

3.88

1.1

1.2

—

Abdominal and pelvic pain

147

1.85

3.87

1.4

—

Pain (limb, back, neck, head abdominally)

2.08

3.86

1.3

1.4

—

Need for other prophylactic measures

7.29

3.86

1.3

1.4

—

Other inflammatory liver diseases

7.29

3.86

1.4

1.5

—

Heart failure and bmi 25plus

2.76

3.85

1.1

1.3

—

Non-rheumatic valve diseases

2.47

3.85

1.3

1.5

—

Parasetamol

106

2.01

3.82

1.4

—

Persons encountering health services in other circumstances, wide

182

1.75

3.81

1.2

1.4

—

Osteopathies and chondropathies

135

2.14

3.80

1.2

1.4

—

Depression medications

3.35

3.78

1.5

1.2

—

Fracture of forearm

133

2.14

3.78

1.5

1.3

—

Implicit fungal Sepsis

8.77

3.77

1.4

1.0

—

Car occupant injured in other and unspecified transport accidents

3.19

3.77

1.5

1.4

—

Acute pancreatitis (for exclusion)

3.18

3.77

1.1

1.3

—

Other maltreatment syndromes

12.05

3.76

1.7

1.6

—

Injuries involving multiple body regions

12.04

3.76

1.7

1.8

—

Other diseases of anus and rectum

2.90

3.71

1.2

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

175

1.83

3.71

1.3

1.4

—

Acute pancreatitis

3.59

3.69

1.1

1.3

—

Superficial injury of shoulder and upper arm

5.01

3.68

1.4

1.3

—

Poisoning by medicine

3.00

3.68

1.3

1.4

—

Alcohol-induced chronic pancreatitis

6.68

3.67

1.1

1.3

—

Pedestrian injured in transport accident

6.68

3.67

1.1

1.5

—

Bronchitis

205

1.75

3.67

1.2

1.4

—

Viral hepatitis

5.64

3.65

1.6

1.4

—

Lower back pain or/and sciatica

209

1.75

3.62

1.3

1.4

—

Misadventures to patients during surgical and medical care

4.41

3.62

1.4

—

Cardiodefibrillation

2.53

3.60

1.1

1.4

—

Injuries to the knee and lower leg

201

1.71

3.60

1.4

1.3

—

Other degenerative diseases of the nervous system

3.88

3.58

1.2

1.6

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

7.80

3.56

1.3

1.0

—

Other disorders of optic [2nd] nerve and visual pathways

7.80

3.56

1.0

1.2

—

Benign neoplasm of brain and other parts of central nervous system

7.80

3.56

1.1

1.4

—

Symptoms and signs involving the urinary system

159

1.92

3.55

1.4

—

Depression or dysthymia

2.12

3.54

1.5

1.2

—

Covid-19 confirmed case

2.44

3.54

1.1

1.3

—

Neurotic, stress-related and somatoform disorders

196

1.78

3.51

1.2

1.4

—

All chronic kidney diseases

100

2.21

3.51

1.1

1.4

—

Myeloproliferative diseases

6.17

3.50

1.0

1.5

—

Other complications of surgical and medical care, not elsewhere classified

6.16

3.50

1.1

1.4

—

Cerebral cysts

10.02

3.50

1.3

—

Deforming dorsopathies

2.70

3.48

1.2

1.4

—

Hard cardiovascular diseases

132

1.90

3.44

1.3

1.4

—

Injuries to unspecified part of trunk, limb or body region

4.55

3.42

1.2

1.3

—

Cardiomyopathies, Primary/intrinsic

4.55

3.42

1.1

1.7

—

Anxiety disorders

197

1.77

3.42

1.2

1.4

—

Valvular heart disease excluding rheumatic fever

2.37

3.41

1.3

1.5

—

Alcohol abuse, main dg

3.52

3.39

1.5

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2.44

3.37

1.6

1.4

—

Other chronic obstructive pulmonary disease, including avohilmo

103

2.17

3.37

1.4

1.3

—

Other and unspecified visual disturbances

5.01

3.37

1.4

—

Disorders of muscles

5.01

3.37

1.0

1.3

—

Streptococcal septicaemia

7.01

3.36

1.4

1.3

—

Elevated blood glucose level

5.72

3.34

2.4

1.4

—

Symptoms and signs concerning food and fluid intake

5.71

3.33

1.5

—

Congenital malformations, deformations and chromosomal abnormalities

173

1.92

3.33

1.3

1.4

—

Congenital malformations and deformations of the musculoskeletal system

5.69

3.32

1.4

—

Hypothyroidism, drug reimbursement

5.30

3.30

1.3

1.2

—

Special screening examination for infectious and parasitic diseases

2.81

3.28

1.3

—

Benign neoplasms

168

1.74

3.27

1.3

1.4

—

Heart failure, strict

102

2.07

3.27

1.1

1.3

—

Other aneurysm

8.59

3.26

1.2

1.1

—

Malignant neoplasm of ovary, including Hilmo

8.59

3.26

1.2

1.6

—

Benign neoplasm: Colon

129

2.07

3.23

1.1

1.4

—

Cardiomyopathy (excluding other)

4.17

3.19

1.1

1.6

—

Explicit bacterial Sepsis

5.34

3.19

1.4

1.3

—

malignant neoplasm of female genital organs

5.31

3.17

1.1

1.5

—

Congenital malformations and deformations of the musculoskeletal system

6.34

3.17

1.0

1.5

—

Use of hypnotics and sedatives

186

1.70

3.17

1.4

1.3

—

Other diseases of urinary system

165

1.74

3.16

1.3

—

Asthma, excluding more controls

107

1.90

3.14

1.4

1.3

—

Pain in joint

2.06

3.14

1.3

1.4

—

Dorsalgia

162

1.72

3.09

1.3

1.4

—

Hernia of abdominal wall

118

2.12

3.09

1.2

1.4

—

Decubitus ulcer and pressure area

7.51

3.05

1.3

1.1

—

Malignant neoplasm of oral cavity, including Hilmo

7.52

3.05

1.2

1.5

—

Other pulmonary diagnosis

118

1.83

3.05

1.4

1.3

—

Scoliosis

7.51

3.05

1.0

1.5

—

5.01

3.05

1.3

1.2

—

Poisoning by drugs, medicaments and biological substances

2.58

3.03

1.4

—

Diseases of the eye and adnexa

133

1.77

3.03

1.4

—

Depression

199

1.70

3.03

1.3

1.4

—

Chronic viral hepatitis

5.85

3.02

1.7

1.6

—

Disorders of optic nerve and visual pathways

5.84

3.02

1.0

1.4

—

Other diseases of liver

3.34

3.01

1.0

1.3

—

All-cause Heart Failure

101

2.03

3.00

1.1

1.3

—

Peripheral artery operations in Hilmo

4.29

2.99

1.3

1.2

—

Thoracic aortic aneurysm

3.55

2.98

1.1

1.4

—

Polycythaemia vera

10.03

2.98

1.0

1.4

—

Unspecified jaundice

10.02

2.98

1.0

1.6

—

COPD/asthma related infections

145

1.73

2.98

1.2

1.4

—

COPD/asthma/ILD related infections

145

1.73

2.98

1.2

1.4

—

Malignant neoplasm of digestive organs

2.45

2.94

1.2

1.4

—

Provisional assignment of new diseases of uncertain etiology

141

1.98

2.92

1.1

1.4

—

Persons encountering health services for specific procedures, not carried out

4.71

2.91

1.4

1.5

—

Diaphragmatic hernia

2.32

2.90

1.1

1.4

—

Codes for special purposes

142

1.97

2.87

1.1

1.4

—

Myeloproliferative diseases (CML excluded)

5.39

2.87

1.0

1.5

—

Barrett oesophagus

6.68

2.87

1.0

1.3

—

Chronic ulcer of skin, not elsewhere classified

5.39

2.87

1.1

1.3

—

L01XX Other antineoplastic agents

6.68

2.87

1.0

1.3

—

Other coagulation defects

6.68

2.86

1.2

1.4

—

Respiratory insufficiency

6.66

2.86

1.0

1.2

—

Malignant neoplasm of breast, ER-negative, including Hilmo

3.67

2.83

1.5

1.4

—

Missing teeth due to accident, extraction or parodontitis

141

1.94

2.82

1.4

1.3

—

Hydrocele

3.34

2.80

1.3

1.4

—

Panic disorder

3.34

2.80

1.1

1.4

—

Speech disturbances, not elsewhere classified

4.45

2.79

1.5

1.2

—

Diverticular disease of intestine

116

1.87

2.78

1.2

1.4

—

Gastroduodenal ulcer

2.64

2.77

1.1

1.4

—

Alcohol withdrawal state with delirium

5.01

2.73

1.3

1.4

—

Acne vulgaris

5.01

2.72

1.3

1.6

—

Codeine

130

1.76

2.72

1.3

1.4

—

Visual impairment including blindness (binocular or monocular)

6.01

2.70

1.0

1.2

—

Diseases of middle ear and mastoid

141

1.86

2.69

1.5

1.3

—

Peritonsillar abscess

2.50

2.69

1.5

1.4

—

Other disorders of the musculoskeletal system and connective tissue

3.45

2.69

1.2

1.3

—

Visual disturbances and blindness

132

1.97

2.68

1.5

1.3

—

Nausea and vomiting

2.59

2.68

1.1

1.2

—

Hypothyroidism and >3 levothyroxin purchases

3.23

2.67

1.1

—

Hypothyroidism, levothyroxine purchases

3.23

2.67

1.1

—

Hypothyroidism (congenital or acquired)

3.23

2.67

1.1

—

Early onset COPD, excluding more controls

3.14

2.63

1.5

1.3

—

Anxiety (asthma-related co-morbidities)

123

1.89

2.63

1.2

1.3

—

Other disorders of skin and subcutaneous tissue

156

1.82

2.59

1.2

1.3

—

Recurrent or chronic depression

2.26

2.59

1.3

1.2

—

DVT of lower extremities and pulmonary embolism

2.14

2.57

1.3

—

Valvular operations

3.60

2.57

1.4

1.7

—

Alzheimer’s disease (Late onset), excluding more controls

5.10

2.57

1.3

—

Nonalcoholic fatty liver disease

4.01

2.56

1.0

1.4

—

Other mental disorders due to brain damage and dysfunction and to physical disease

4.00

2.56

1.5

1.4

—

Hypokalaemia

4.00

2.56

1.0

1.3

—

Other metabolic disorders

4.00

2.56

1.1

1.3

—

Haemorrhage from respiratory passages

2.25

2.56

1.3

1.4

—

Asthma

116

1.76

2.56

1.4

1.3

—

Selective serotonin reuptake inhibitors

151

1.66

2.56

1.5

1.4

—

Hepatocellular carcinoma

7.18

2.55

1.4

1.0

—

Attention to artificial openings

7.16

2.55

1.2

1.3

—

Contact with heat and hot substances

7.15

2.55

1.2

1.6

—

Osteonecrosis

5.47

2.54

1.3

1.6

—

Injury of unspecified body region

5.46

2.54

1.0

1.2

—

Other congenital malformations

5.46

2.54

1.3

1.4

—

Other diseases of blood and blood-forming organs, wide

2.60

2.52

1.3

—

Cellulitis

2.50

2.52

1.1

1.4

—

Other reaction to severe stress, and adjustment disorders

101

2.08

2.52

1.1

1.4

—

Ulcer of lower limb, not elsewhere classified

3.23

2.51

1.3

—

Ischaemic Stroke, excluding all haemorrhages

1.95

2.51

1.3

—

Episodal and paroxysmal disorders

176

1.59

2.48

1.3

1.4

—

Motorcycle rider injured in other and unspecified transport accidents

4.38

2.47

1.6

1.4

—

Injury of muscle and tendon at hip and thigh level

4.38

2.47

1.3

1.4

—

Peripheral artery disease

2.24

2.47

1.3

1.4

—

Abnormalities of gait and mobility

3.81

2.46

1.4

1.3

—

Other symptoms and signs involving cognitive functions and awareness

105

1.99

2.44

1.1

1.4

—

Benign neoplasm of colon, rectum, anus and anal canal

143

1.82

2.44

1.1

1.4

—

Any dementia

2.32

2.43

1.4

1.2

—

176

1.59

2.42

1.1

1.4

—

Ovarian dysfunction

5.01

2.40

1.0

1.2

—

Haemangioma, any site

5.01

2.40

1.7

1.3

—

Hernia

190

1.62

2.40

1.1

1.4

—

Insulin, intermediate and long-acting

141

1.86

2.39

1.2

1.4

—

Atrial fibrillation and flutter with reimbursement

2.67

2.39

1.1

1.3

—

Problems related to lifestyle

4.12

2.36

1.6

1.3

—

Acne

4.12

2.35

1.3

1.5

—

Asthma (diagnoses ohter than nonallergic)

213

1.64

2.35

1.3

—

Atherosclerosis, excluding cerebral and coronary sclerosis

2.30

2.34

1.2

1.4

—

Presence of cardiac and vascular implants and grafts

2.05

2.33

1.4

1.3

—

Gout

2.42

2.31

1.1

1.3

—

Fracture of foot, except ankle

2.31

1.5

1.4

—

Superficial injury of abdomen, lower back and pelvis

3.22

2.30

1.1

1.3

—

Assault

2.94

2.28

1.7

1.4

—

Adjustment and management of implanted device

2.94

2.27

1.1

1.2

—

Cholangitis (primary sclerosing, PSC)

4.62

2.27

1.2

1.4

—

Ulcer of oesophagus

4.62

2.27

1.0

1.2

—

Leisure time condition

2.75

2.27

1.4

1.3

—

Open wound of forearm

3.48

2.27

1.8

1.3

—

Polycystic ovarian syndrome, broad definition

3.48

2.27

1.0

1.3

—

Other and unspecified nonorganic psychotic disorders

2.56

2.26

2.2

1.4

—

Benzodiazepine use

215

1.57

2.26

1.5

1.3

—

Injuries to the wrist and hand

217

1.56

2.24

1.4

1.3

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.47

2.23

1.4

—

Abnormal findings on examination of blood, without diagnosis

110

1.92

2.22

1.7

1.3

—

Other diseases of intestine

3.11

2.22

1.1

1.3

—

Gastric ulcer

2.86

2.20

1.2

—

Benign neoplasm: Colon, unspecified

2.41

2.19

1.1

1.2

—

Ventral hernia

2.50

2.18

1.1

1.4

—

Asthma (mode)

117

1.69

2.18

1.4

1.3

—

COPD differential diagnosis

117

1.67

2.15

1.4

1.3

—

ILD differential diagnosis

117

1.67

2.15

1.4

1.3

—

Haemangioma and lymphangioma, any site

4.29

2.15

1.7

1.2

—

ILD, hospital admission 2, with pulmonary infections

4.29

2.15

1.0

1.4

—

Delirium, not induced by alcohol and other psychoactive substances

3.68

2.14

1.0

1.3

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.00

2.14

1.0

1.3

—

Any dementia, excluding more controls

2.29

2.12

1.3

1.2

—

COPD

1.99

2.11

1.4

1.3

—

Cardiac arrest

5.35

2.10

1.4

1.5

—

Phlebitis and thrombophlebitis (not including DVT)

2.45

2.10

1.4

1.3

—

Excluding asthma or asthma-COPD overlap

118

1.66

2.10

1.4

1.3

—

Other hearing loss

2.36

2.09

1.4

1.2

—

Any reimbursement code in KELA

1.90

2.08

1.4

1.5

—

Lichen simplex chronicus and prurigo

5.01

2.07

1.2

—

Postprocedural musculoskeletal disorders, not elsewhere classified

5.01

2.07

1.4

1.2

—

Malignant neoplasm of corpus uteri, including Hilmo

5.00

2.07

1.0

1.5

—

Nonsuppurative otitis media

2.29

2.07

1.6

1.3

—

Procreative management

2.06

2.07

1.4

—

Unspecified dementia

4.15

2.06

1.7

1.1

—

Spondylolisthesis/Spondylolysis

2.70

2.06

1.2

1.5

—

Schizophrenia or delusion, excluding more controls

2.18

2.05

1.9

1.3

—

Later onset COPD, excluding more controls

3.25

2.05

1.4

1.7

—

Other pleural conditions

3.50

2.05

1.1

1.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

3.50

2.05

1.0

1.3

—

Pedal cyclist injured in transport accident

2.32

2.04

1.2

1.4

—

Dementia

2.13

2.04

1.4

1.3

—

Atrial fibrillation and flutter

2.26

2.04

1.1

1.4

—

Female infertility

2.28

2.03

1.0

1.2

—

Other respiratory disorders and diseases

2.63

2.00

1.1

1.2

—

Other diseases of the respiratory system

2.63

2.00

1.1

1.2

—

ILD medications: azathioprine

2.81

2.00

1.4

—

COPD, hospital admissions

1.94

1.99

1.5

1.3

—

Other chronic obstructive pulmonary disease

1.98

1.99

1.4

1.3

—

Mental and behavioural disorders due to sedatives or hypnotics

4.55

1.94

1.6

1.5

—

Benign neoplasm of bone and articular cartilage

4.55

1.94

1.0

1.4

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2.19

1.94

1.1

1.4

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.57

1.94

1.6

1.3

—

Exposure to other and unspecified inanimate mechanical forces

3.75

1.93

1.0

1.4

—

Other diseases of pancreas

3.75

1.93

1.2

1.3

—

Mixed and other personality disorders

3.75

1.93

1.3

1.6

—

Senile cataract

1.75

1.93

1.0

1.4

—

General examination and investigation of persons without complaint and reported diagnosis

1.84

1.93

1.3

1.4

—

External causes of morbidity and mortality

1.84

1.92

1.2

1.4

—

Degenerative diseases of the nervous system

2.24

1.92

1.3

1.2

—

Asthma-related infections

154

1.72

1.90

1.3

1.4

—

Asthma, hospital admission 2, infections

154

1.72

1.90

1.3

1.4

—

Other arthrosis

1.79

1.89

1.4

—

Cerebral palsy and other paralytic syndromes

3.18

1.88

1.1

1.3

—

Factors influencing health status and contact with health services

2.63

1.86

1.5

1.4

—

Superficial injury of hip and thigh

2.86

1.86

1.4

1.2

—

Dorsopathies

165

1.51

1.85

1.3

1.4

—

Maternal care for known or suspected fetal abnormality and damage

2.67

1.85

1.2

1.4

—

Polyuria

2.39

1.85

1.3

—

Oedema, not elsewhere classified

2.21

1.84

1.0

1.5

—

Other/unspecified synovitis and tenosynovitis

3.53

1.83

1.0

1.2

—

Fentanyl

3.53

1.83

1.2

1.4

—

Disorders of lens

121

1.65

1.82

1.1

1.4

—

Cardiomyopathy, other and unspecified

4.17

1.82

1.2

1.5

—

Other and unspecified drugs and medicaments

4.17

1.82

1.2

1.4

—

ILD, hospital admissions 3, with pneumonia sepsis

4.17

1.82

1.0

1.5

—

Reactive arthropathies

4.17

1.82

1.0

1.1

—

Spontaneous rupture of synovium and tendon

4.17

1.82

1.2

1.3

—

Umbilical hernia

2.12

1.81

1.4

1.5

—

Hypertension, essential

127

1.60

1.81

1.4

—

Postpartum haemorrhage due to anatomy

3.05

1.80

1.3

—

Mucosal proctocolitis

2.76

1.79

1.6

1.3

—

Angina pectoris

100

1.73

1.78

1.5

1.2

—

Infections of the skin and subcutaneous tissue

175

1.64

1.76

1.3

1.4

—

Aortic valve malfunction, age under 60 years

3.34

1.74

1.8

1.4

—

Other symptoms and signs involving the urinary system

3.34

1.74

1.0

1.3

—

Herpesviral [herpes simplex] infections

3.34

1.74

1.0

1.4

—

Azathioprine

2.50

1.73

1.4

—

Chronic kidney disease

2.08

1.73

1.1

1.3

—

Disorders of sclera, cornea, iris and ciliary body

147

1.70

1.73

1.4

1.3

—

Sciatica+with lumbago

121

1.75

1.72

1.2

1.4

—

Atrophic disorders of skin

2.92

1.72

1.0

1.3

—

Care involving dialysis

3.85

1.71

1.2

1.3

—

Mental and behavioural disorders due to tobacco

3.85

1.71

1.0

1.4

—

Pruritus

3.85

1.71

1.4

1.2

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

2.22

1.71

1.4

1.3

—

Malignant neoplasm of breast, including Hilmo

2.22

1.71

1.4

1.3

—

ILD medications

198

1.45

1.71

1.2

1.4

—

Haemorrhoids and perianal venous thrombosis

2.13

1.70

1.4

1.3

—

COPD (mode)

2.25

1.69

1.3

1.4

—

Non-selective monoamine reuptake inhibitors

2.01

1.69

1.2

1.3

—

Fracture at wrist and hand level

1.87

1.69

1.4

—

Insulin, combination of fast acting with intermediate-acting or long-acting

156

1.64

1.68

1.2

1.4

—

Malignant neoplasm of breast, HER-negative

2.86

1.68

1.0

1.5

—

COPD, hospital admission 2, with asthma infections

2.07

1.67

1.4

1.3

—

Enterocolitis due to Clostridium difficile

3.16

1.66

1.3

1.2

—

Other congenital malformations

3.16

1.66

1.3

1.4

—

All anxiety disorders

147

1.61

1.65

1.2

1.4

—

COPD, early/later onset

1.84

1.65

1.4

1.3

—

Endocrine, nutritional and metabolic diseases

132

1.53

1.65

1.3

1.4

—

Keratitis

1.86

1.65

1.3

1.4

—

Disturbances of skin sensation

2.10

1.65

1.2

1.3

—

Disorder of lipoprotein metabolism, unspecified

2.80

1.65

1.4

1.2

—

Female infertility, cervical, vaginal, other or unspecified origin

2.17

1.64

1.0

1.2

—

Obesity due to excess calories

127

1.73

1.63

1.2

1.4

—

Paralytic ileus and intestinal obstruction

2.24

1.63

1.1

1.2

—

Pneumonitis due to solids and liquids

3.57

1.61

1.0

1.4

—

Smoking dependency

3.57

1.61

1.0

1.4

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

3.57

1.61

1.2

1.6

—

Superficial injury of forearm

3.57

1.61

1.6

1.3

—

Diseases of oesophagus, stomach and duodenum

193

1.46

1.59

1.1

1.4

—

Disorders of other endocrine glands

104

1.80

1.59

1.4

1.3

—

Intestinal stricture

2.00

1.58

1.3

1.2

—

Persons with potential health hazards related to communicable diseases

105

1.79

1.58

1.2

1.4

—

Abnormal weight loss

3.00

1.58

1.0

1.3

—

Hypopituitarism

3.00

1.58

1.5

—

Other viral diseases

1.94

1.57

1.1

1.4

—

Irritable bowel syndrome

2.11

1.54

1.3

—

Personality disorders, excluding more controls

2.11

1.54

1.3

1.4

—

Medical treatment for female infertility

2.26

1.54

1.0

1.4

—

Heart failure and coronary heart disease

1.88

1.54

1.1

1.2

—

Hyperlipidaemia, other/unspecified

1.89

1.54

1.2

1.3

—

Dislocation, sprain and strain of joints and ligaments at neck level

2.43

1.53

1.0

1.3

—

Gout, FINNGEN

1.97

1.52

1.1

1.4

—

Benign neoplasm: Descending colon

3.34

1.52

1.0

1.2

—

Event of undetermined intent

3.34

1.52

1.8

1.4

—

Benign neoplasm: Parotid gland

3.34

1.52

1.0

1.3

—

Other infectious diseases

3.34

1.52

1.4

1.3

—

Malignant neoplasm of urinary organs

3.34

1.52

1.0

1.3

—

Uterine polyps

3.34

1.52

1.0

1.1

—

Family history of malignant neoplasm

3.34

1.52

1.8

1.5

—

Malignant neoplasm of head and neck

3.33

1.52

1.4

—

Undetermined asthma

3.33

1.52

1.4

1.3

—

Undefined dementia

2.91

1.52

1.7

1.1

—

Other/unspecified dorsalgia

1.83

1.51

1.1

1.4

—

Hallux rigidus

2.59

1.51

1.0

1.2

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2.59

1.51

1.1

1.3

—

Weight loss

2.86

1.50

1.0

1.3

—

Alzheimer’s disease (Late onset)

2.52

1.50

1.3

1.1

—

Amputation

2.86

1.50

1.5

1.2

—

Disorders of psychological development

2.60

1.50

1.6

1.7

—

Visual disturbances

123

1.71

1.50

1.6

1.3

—

Certain infectious and parasitic diseases

102

1.57

1.48

1.4

—

Persons encountering health services in other circumstances

101

1.77

1.46

1.3

1.4

—

Alzheimer’s disease, strict definition

2.39

1.46

1.3

1.1

—

Bacterial intestinal infections, IBD co-morbidities

2.37

1.45

1.2

—

Myopia

2.50

1.45

1.4

1.2

—

Soft tissue disorders

169

1.43

1.44

1.2

1.4

—

Paroxysmal tachycardia

2.35

1.44

1.1

1.4

—

Graves disease, strict definition

3.13

1.44

1.0

1.4

—

Undetermined asthma, excluding more controls

3.12

1.43

1.4

1.5

—

Other disorders of eye and adnexa

2.73

1.43

1.5

1.4

—

Obesity

173

1.56

1.43

1.3

—

Use of donepezil

2.48

1.43

1.3

1.1

—

Obesity and other hyperalimentation

173

1.56

1.42

1.3

—

Non-invasive ventilation

2.30

1.41

1.1

1.4

—

Other disorders of bone

2.25

1.40

1.0

1.5

—

Other CVD

2.25

1.40

1.7

1.2

—

Coronary revascularization (ANGIO or CABG)

143

1.50

1.39

1.3

—

Pleural effusion

2.42

1.39

1.6

1.4

—

Early onset COPD

2.08

1.38

1.5

1.3

—

Hypertensive diseases

132

1.50

1.37

1.5

1.4

—

Hypertension

132

1.50

1.37

1.5

1.4

—

Hypertensive heart and/or renal disease

2.04

1.36

1.1

1.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.61

1.36

1.8

1.3

—

Dementia, including avohilmo

1.83

1.36

1.3

—

Other specified/unspecified hearing loss

2.94

1.36

1.4

1.2

—

Other viral diseases

111

1.70

1.35

1.1

1.5

—

Disorders of lipoprotein metabolism and other lipidaemias

136

1.50

1.34

1.5

1.3

—

Cholecystectomy

157

1.54

1.34

1.1

1.3

—

Pure hypercholesterolaemia

128

1.53

1.34

1.5

1.3

—

Other bacterial intestinal infections

2.14

1.33

1.2

—

Gout, unspecified

2.13

1.33

1.1

1.4

—

Disorders of synovium and tendon

132

1.59

1.32

1.3

1.4

—

Alzheimer disease, including avohilmo

2.01

1.31

1.3

1.1

—

Insulin medication

154

1.53

1.30

1.2

1.4

—

COPD-related respiratory insufficiency

2.50

1.30

1.0

1.3

—

Other skin changes

2.50

1.30

1.5

1.1

—

Cholelithiasis

148

1.49

1.29

1.1

1.4

—

Visual field defects

2.78

1.28

1.6

1.3

—

Benign neoplasm: salivary glands, exclude unknown (D119)

2.78

1.28

1.0

1.4

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2.07

1.28

1.2

1.4

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

2.77

1.28

1.4

1.2

—

Gastro-oesophageal reflux disease

152

1.53

1.28

1.1

1.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

194

1.38

1.27

1.2

1.4

—

First line medication for Crohn's disease

192

1.38

1.27

1.2

1.4

—

Persistent mood disorders

2.05

1.26

1.4

1.3

—

Malignant neoplasm of breast, HER2-negative

2.06

1.25

1.0

1.3

—

Other specific joint derangements/joint disorders

150

1.46

1.25

1.3

1.4

—

Other anxiety disorders

119

1.60

1.25

1.3

1.4

—

Other functional intestinal disorders

1.71

1.25

1.3

—

Other CVD (FINNGEN)

2.77

1.24

1.6

1.4

—

Chronic periodontitis, complicated

145

1.57

1.24

1.3

1.4

—

Open wound of lower leg

2.22

1.24

1.3

—

Diseases of the respiratory system

1.57

1.24

1.3

1.4

—

Calculus of kidney and ureter

1.86

1.23

1.2

1.4

—

Symptoms and signs involving speech and voice

1.86

1.23

1.5

1.3

—

Presbycusis

2.38

1.23

1.5

1.0

—

Percutaneous Coronary Intervention

143

1.46

1.22

1.3

—

Gout, idiopatic and unspecified

1.97

1.22

1.1

1.3

—

Infective dermatitis

2.63

1.21

1.0

1.2

—

Coronary artery bypass grafting

2.00

1.21

2.4

1.3

—

Vocal cord dysfunction

2.64

1.20

1.2

1.5

—

Alzheimer disease, excluding more controls

2.75

1.20

1.0

1.6

—

Propionic acid derivatives

0.43

1.20

1.4

—

Asthma, including avohilmo

217

1.35

1.19

1.4

1.3

—

Cholelithiasis, broad definition with cholecystitis

153

1.45

1.18

1.1

1.4

—

Pedal cyclist injured in noncollision transport accidents

2.31

1.18

1.3

1.4

—

Other bursopathies

2.31

1.18

1.2

1.3

—

Gout, strict definition

2.11

1.18

1.1

1.3

—

Emergency coronary revascularization (for ACS)

153

1.43

1.18

1.3

—

Gonarthrosis [arthrosis of knee](FG)

127

1.46

1.17

1.2

1.4

—

Dyspnoea

200

1.40

1.17

1.1

1.4

—

Obesity, other/unspecified

1.70

1.17

1.4

—

Used for control exclusion in common control thyroid runs

178

1.36

1.16

1.4

—

Diseases of oral cavity, salivary glands and jaws

1.53

1.16

1.3

—

Lichen planus, including avohilmo

0.00

1.16

0.0

1.3

—

Amiodarone users

2.50

1.15

1.2

1.3

—

Benign neoplasm of major salivary glands

2.50

1.15

1.0

1.4

—

Impacted cerumen

2.50

1.15

1.2

1.3

—

Pedal cyclist injured in other and unspecified transport accidents

2.50

1.15

1.4

1.3

—

Other or unspecified ileus, impaction or obstruction

2.05

1.15

1.1

1.2

—

Other nutritional deficiencies

179

1.47

1.14

1.3

—

Asthma (only as main-diagnosis), excluding more controls

107

1.50

1.13

1.2

1.3

—

Dizziness and giddiness

157

1.46

1.12

1.2

1.3

—

Kela-code for severe mental illness

103

1.65

1.12

1.8

1.4

—

Long labour

1.99

1.12

1.8

1.3

—

Dilated cardiomyopathy

2.34

1.12

1.1

1.2

—

ILD, hospital admissions

2.33

1.12

1.0

1.3

—

Interstitial lung disease

2.33

1.12

1.0

1.3

—

Other interstitial pulmonary diseases

2.33

1.12

1.0

1.3

—

Interstitial lung disease endpoints

2.33

1.12

1.0

1.3

—

Colorectal adenocarcinoma

2.33

1.12

1.3

1.4

—

Hallux valgus (acquired)

1.88

1.12

1.4

1.3

—

Cervicalgia

2.00

1.12

1.0

1.4

—

Pain in thoracic spine

2.26

1.10

1.1

1.4

—

Nontoxic multinodular goitre

2.26

1.10

1.4

1.2

—

Diseases of the skin and subcutaneous tissue

170

1.36

1.10

1.4

1.3

—

Abnormalities of breathing

168

1.38

1.10

1.3

1.4

—

Transient ischemic attack

1.60

1.09

1.3

—

Benign neoplasm of mouth and pharynx

2.38

1.09

1.2

1.4

—

Candidiasis

2.38

1.09

1.0

1.4

—

Nonischemic cardiomyopathy

2.38

1.09

1.2

1.5

—

Corneal ulcer

1.95

1.08

1.0

1.3

—

Other dorsopathies, not elsewhere classified

165

1.36

1.07

1.1

1.4

—

Periodontitis

201

1.36

1.07

1.2

1.4

—

Nerve, nerve root and plexus disorders

210

1.34

1.07

1.3

—

Use of anticholinesterases

1.89

1.06

1.3

1.1

—

N06DA Anticholinesterases

1.89

1.06

1.3

1.1

—

Fissure and fistula of anal and rectal regions

1.92

1.06

1.2

1.4

—

Chronic periodontitis, including avohilmo

202

1.36

1.06

1.2

1.4

—

Benign neoplasm of other and ill-defined parts of digestive system

2.12

1.05

1.0

1.2

—

Congenital malformations of the circulatory system

2.12

1.05

1.3

—

Chronic apical periodontitis

211

1.32

1.03

1.3

1.4

—

Duodenal ulcer

2.27

1.03

1.0

1.3

—

Asthma (only as main-diagnosis)

116

1.45

1.02

1.2

1.3

—

Other bacterial intestinal infections

1.83

1.02

1.3

—

Urolithiasis

1.73

1.02

1.2

1.4

—

Ischemic heart diseases

146

1.40

1.02

1.3

—

Other disorders of veins

1.66

1.01

1.3

—

Open wound of wrist and hand

135

1.52

1.01

1.7

1.4

—

Diseases of external ear

1.69

1.01

1.4

1.3

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.76

1.01

1.5

—

Excessive, frequent and irregular menstruation

1.74

1.01

1.1

1.2

—

Arthropathies

153

1.36

1.00

1.3

1.4

—

Schizophrenia or delusion

1.65

1.00

1.9

1.4

—

Schizophrenia, schizotypal and delusional disorders

1.65

1.00

1.9

1.4

—

Cystitis

135

1.41

1.00

1.3

—

Conduction disorders

1.87

0.99

1.0

1.6

—

Insulin, fast-acting

1.62

0.99

1.1

1.4

—

COPD related to multimorbidity

1.69

0.99

1.4

1.3

—

Polyneuropathies and other disorders of the peripheral nervous system

1.84

0.98

1.2

1.3

—

Mycoses

1.80

0.98

1.2

1.3

—

Injury, poisoning and certain other consequences of external causes

1.61

0.98

1.3

—

Cough

1.61

0.97

1.3

1.4

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.95

0.97

1.7

1.3

—

Diseases of the ear and mastoid process

192

1.31

0.97

1.4

1.3

—

Unspecified mental disorder

116

1.55

0.96

1.7

1.4

—

Polyp of the female genital tract

1.92

0.95

1.2

—

Gonarthrosis

102

1.45

0.95

1.2

1.4

—

Other disorders of ear

179

1.35

0.94

1.4

1.3

—

Fibroblastic disorders

1.77

0.94

1.2

1.4

—

Alzheimer disease

1.78

0.94

1.4

1.1

—

Delivery

0.48

0.94

1.4

1.3

—

Other respiratory diseases principally affecting the interstitium

1.89

0.94

1.0

1.2

—

Zoster [herpes zoster]

123

1.52

0.93

1.3

—

Acute upper respiratory infections of multiple and unspecified sites

172

1.38

0.93

1.3

1.4

—

Other joint disorders

153

1.34

0.92

1.3

1.4

—

Tooth eruption problems

2.17

0.92

1.3

1.4

—

Thyrotoxicosis with diffuse goitre

2.14

0.91

1.0

1.4

—

Diabetes mellitus in pregnancy

1.75

0.91

1.0

1.3

—

Necrosis of pulp, including avohilmo

167

1.43

0.90

1.2

1.4

—

Superficial injury of lower leg

1.75

0.90

1.3

—

Monoamine oxidase A inhibitors

2.07

0.89

1.7

1.3

—

Ulcerative colitis, NAS

2.07

0.89

1.7

1.3

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2.07

0.89

1.2

1.4

—

Major coronary heart disease event

151

1.36

0.89

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

217

1.31

0.88

1.3

1.4

—

Anti-inflammatory and antirheumatic products, non-steroids

0.52

0.88

1.3

1.4

—

Gestational diabetes (for exclusion)

1.67

0.88

1.1

1.3

—

Arthrosis

114

1.40

0.87

1.3

1.4

—

Injury of muscle and tendon at lower leg level

1.82

0.85

1.1

1.4

—

Malignant neoplasm of breast

1.81

0.85

1.0

1.3

—

All influenza (not pneumonia)

1.94

0.84

1.8

1.3

—

Injury of muscle and tendon at shoulder and upper arm level

1.63

0.84

1.3

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.78

0.84

1.6

1.4

—

Chronic lower respiratory diseases

214

1.27

0.83

1.3

—

Lumbar disc prolapse

137

1.40

0.82

1.2

1.4

—

Insulin, fast-acting or short human

105

1.52

0.81

1.1

1.4

—

Disorders of adult personality and behaviour

1.61

0.81

1.5

1.4

—

Intestinal infectious diseases

216

1.27

0.80

1.3

1.4

—

Acute laryngitis and tracheitis

1.84

0.80

1.3

1.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

183

1.29

0.79

1.4

—

Radiculopathy

1.82

0.79

1.0

1.4

—

Non-allergic asthma (mode), excluding more controls

1.80

0.78

1.0

1.3

—

Obesity related asthma

1.59

0.78

1.3

1.4

—

Postpartum care and examination

2.26

0.78

1.0

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.71

0.76

1.7

1.4

—

Peripheral arterial reconstruction

1.76

0.76

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

174

1.28

0.76

1.4

—

Excessive earwax

145

1.41

0.76

1.3

1.4

—

Striking against or struck by other objects

1.51

0.75

1.1

1.5

—

Meniscus derangement

105

1.41

0.75

1.2

1.4

—

Acute upper respiratory infections

203

1.27

0.74

1.2

1.4

—

Diseases of the myoneural junction and muscle

2.08

0.74

1.6

1.3

—

Bell's palsy

2.08

0.74

1.4

1.3

—

Primary_lymphoid and hematopoietic malignant neoplasms

1.67

0.74

1.3

1.2

—

Dislocation, sprain and strain of joints and ligaments of knee

161

1.37

0.74

1.3

—

Pain in throat and chest

161

1.31

0.74

1.2

1.4

—

Zoster [herpes zoster]

1.84

0.73

1.1

1.2

—

Nonorganic sleeping disorders, excluding more controls

1.84

0.73

1.0

1.3

—

Dementia in Alzheimer disease

2.01

0.72

1.2

1.1

—

Benign neoplasm of other and unspecified endocrine glands

2.00

0.72

1.0

1.3

—

Other embolism and thrombosis

2.00

0.72

1.0

1.3

—

Lung diseases due to external agents

2.00

0.72

1.0

1.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

202

1.28

0.72

1.2

1.4

—

Other and unspecified urticaria

1.80

0.72

1.6

1.4

—

Exclusions for E4_PCOS_BROAD

1.79

0.72

1.4

1.3

—

Antenatal screening

1.79

0.72

1.7

1.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.79

0.72

1.3

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.52

0.72

1.2

1.4

—

Schizophrenia

1.75

0.71

2.4

1.4

—

Ulcerative colitis (strict definition, require KELA)

1.75

0.71

1.7

1.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.75

0.71

1.1

1.4

—

Injuries to the ankle and foot

195

1.32

0.71

1.5

1.3

—

Herpesviral [herpes simplex] infections

1.58

0.71

1.0

1.3

—

All influenza

1.58

0.71

1.6

1.3

—

Use of rivastigmine

1.92

0.70

1.2

—

Ovarian cyst

1.61

0.70

1.3

1.2

—

Colorectal cancer

1.71

0.70

1.3

1.4

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.71

0.70

1.4

1.3

—

Nontoxic goitre/thyroid nodule

1.55

0.69

1.3

1.2

—

117

1.44

0.69

1.3

1.4

—

Viral infections characterized by skin and mucous membrane lesions

118

1.44

0.68

1.1

1.4

—

Diabetic nephropathy, excluding more controls

1.87

0.68

1.0

1.4

—

Use of disulfiram, acamprosate or naltrexone

1.85

0.68

1.6

1.4

—

Benign neoplasm: Ascending colon

1.85

0.68

1.0

1.2

—

Trigger finger

1.85

0.68

1.0

1.4

—

Malignant neoplasm of colon, including Hilmo

1.85

0.68

1.4

—

Personality disorders

1.56

0.68

1.3

1.4

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.56

0.68

1.2

1.4

—

Other and unspecified polyneuropathies, also in other diseases

1.67

0.68

1.0

1.3

—

Candidiasis

1.59

0.68

1.1

1.2

—

AV-block

1.83

0.67

1.0

1.8

—

COPD, hospital admissions 1, only main diagnosis

1.60

0.67

1.2

1.3

—

Other cataract

1.46

0.66

1.1

1.4

—

Leiomyoma of uterus

0.60

0.66

2.0

1.2

—

Retinal detachment with retinal break

1.79

0.66

1.2

1.4

—

ILD, hospital admissions 1, main diag only

1.79

0.66

1.0

1.3

—

Acute pharyngitis

1.61

0.66

1.0

1.3

—

Cardiac arrhythmias

1.40

0.66

1.1

1.4

—

Acute suppurative otitis media

1.58

0.65

1.3

—

Polyarthropathies

128

1.33

0.64

1.2

1.4

—

Acute and transient psychotic disorders

1.72

0.64

2.6

1.4

—

Unspecific neurodegenerative disorder

1.55

0.63

1.2

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

169

1.25

0.62

1.4

—

Abrasion of teeth

1.52

0.62

1.0

1.3

—

Female genital prolapse

1.61

0.62

1.1

1.2

—

Other disorders of amniotic fluid and membranes

1.68

0.62

1.2

—

Other menopausal disorders

1.61

0.62

1.5

1.2

—

Specific personality disorders

1.59

0.61

1.6

1.3

—

Ectopic pregnancy

1.67

0.61

1.0

1.4

—

Other disorders of penis

1.67

0.61

1.4

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.48

0.60

1.5

1.3

—

Adenomyosis (Endometriosis of uterus)

0.00

0.60

0.0

1.3

—

Abnormalities of forces of labour

0.00

0.60

0.0

1.4

—

Other disorders of breast

0.00

0.60

0.0

1.4

—

Infections with a predominantly sexual mode of transmission

1.48

0.60

1.2

1.4

—

Codeine or tramadol medication

201

1.22

0.60

1.3

1.4

—

Lichen planus

0.00

0.59

0.0

1.4

—

Hypertensive Heart Disease

1.53

0.59

1.1

1.4

—

Systemic connective tissue disorders

1.53

0.59

1.2

1.3

—

Glomerular disorders in diseases classified elsewhere

0.00

0.58

0.0

1.4

—

Carpal tunnel syndrome

146

1.33

0.58

1.3

—

Colectomy operation

1.71

0.57

1.3

—

Somatoform disorder

1.71

0.57

1.2

1.4

—

Non-allergic asthma (mode)

1.70

0.57

1.0

1.3

—

Autoimmune diseases excluding thyroid diseases

192

1.22

0.57

1.4

—

Diseases of salivary glands

1.48

0.57

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.66

0.56

1.3

—

Abnormal serum enzyme levels

1.51

0.56

1.5

1.3

—

Hyperparathyroidism

1.65

0.56

1.7

1.2

—

Diabetes, varying definitions

191

1.23

0.56

1.2

1.4

—

Mycoses

238

1.24

0.56

1.4

1.3

—

Colonic or urogenital fistula

1.54

0.55

1.2

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.62

0.55

1.3

1.4

—

Later onset COPD

1.53

0.55

1.4

1.3

—

Disorders of parathyroid gland

1.60

0.55

1.7

1.2

—

Acute appendicitis, no complications

182

0.71

0.55

1.1

1.4

—

Disorders of refraction and accommodation

1.53

0.54

1.7

1.3

—

Dental pulpitis, including avohilmo

195

1.23

0.54

1.1

1.4

—

Disorders of vitreous body and globe

120

0.64

0.54

1.4

1.3

—

Functional dyspepsia

1.50

0.54

1.0

1.4

—

Autoimmune diseases

194

1.21

0.54

1.4

—

Temporomandibular joint disorders, including avohilmo

115

1.37

0.52

1.3

—

Primary gonarthrosis, bilateral

107

1.36

0.52

1.3

—

Asthma, hospital admissions , main diagnosis only

220

1.24

0.52

1.2

1.4

—

Gastrointestinal diseases

1.31

0.52

1.3

1.4

—

Other diseases of hard tissues of teeth

1.31

0.52

1.4

1.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

152

1.32

0.51

1.4

1.3

—

Other disorders of lacrimal gland

1.45

0.51

1.4

1.3

—

Erosion of teeth , including avohilmo

1.41

0.51

1.1

1.4

—

Other arrhythmias

108

1.33

0.50

1.2

1.4

—

Artrosis, including avohilmo

146

1.24

0.50

1.2

1.4

—

Bipolar affective disorders

1.46

0.50

1.2

1.4

—

Suppurative and unspecified otitis media

1.39

0.50

1.4

—

Coxibs

1.42

0.50

1.4

—

Use of pramipexole

1.56

0.48

1.3

1.2

—

Disorders of breast

100

0.64

0.48

1.7

1.2

—

Internal derangement of knee

101

1.38

0.48

1.4

—

Obstructed labour due to malposition and malpresentation of fetus

1.52

0.48

1.7

1.3

—

Postmenopausal bleeding

1.49

0.48

1.0

1.2

—

Fenamates

1.48

0.47

1.1

1.3

—

Intestinal infectious diseases

233

1.20

0.47

1.4

1.3

—

Polycystic ovarian syndrome, consortium definition

1.30

0.46

1.2

—

Superficial injury of wrist and hand

1.43

0.46

1.4

1.3

—

Disorders of vitreous body

117

0.66

0.45

1.4

1.3

—

Otitis externa

1.40

0.45

1.6

1.4

—

Hypothyroidism, other/unspecified

167

1.22

0.44

1.2

1.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.45

0.44

1.1

1.3

—

Nonorganic sleeping disorders

1.37

0.44

1.0

1.4

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.37

0.44

1.1

1.4

—

Diabetic retinopathy, excluding more controls

1.45

0.43

1.0

1.3

—

Continuous positive airway pressure

1.62

0.43

1.4

1.5

—

Budesonide

1.61

0.43

1.2

1.5

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

1.61

0.43

2.0

1.3

—

Viral infections characterized by skin and mucous membrane lesions

235

1.20

0.42

1.2

1.4

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1.56

0.42

1.8

1.3

—

Acute appendicitis

214

0.79

0.42

1.1

1.4

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

174

1.21

0.42

1.2

1.3

—

Allergic rhinitis

0.63

0.42

1.2

1.4

—

Menorrhagia

1.46

0.42

1.1

1.2

—

Diseases of the musculoskeletal system and connective tissue

1.27

0.41

1.4

1.5

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

0.41

0.0

1.3

—

Normotensive glaucoma

0.00

0.41

0.0

1.2

—

Asthma/COPD (KELA code 203)

214

1.19

0.41

1.2

1.3

—

Haemorrhage in early pregnancy

1.37

0.41

1.4

1.3

—

Non-small cell lung cancer

0.00

0.41

0.0

1.1

—

Other hammer toe(s) (acquired)

1.49

0.40

1.2

1.1

—

Spirochaetal infections, other/unspecified

0.00

0.40

0.0

1.3

—

Viral warts

0.00

0.40

0.0

1.4

—

Chondropathies

1.47

0.40

1.0

1.3

—

Hypotension

1.47

0.40

1.6

1.2

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.40

0.0

1.3

—

Finngen Rheumatological endpoints

183

1.18

0.40

1.2

1.4

—

Other and unspecified disorders of vitreous body

100

0.69

0.39

1.4

1.3

—

Myocardial infarction, with ST-elevation

1.43

0.39

1.6

1.3

—

Diabetes mellitus

194

1.17

0.39

1.2

1.4

—

Disorders of choroid and retina

177

0.80

0.39

1.3

1.4

—

Other diseases of lip and oral mucosa

106

1.32

0.39

1.1

1.4

—

Cutaneous abscess, furuncle and carbuncle

1.34

0.38

1.3

1.4

—

Diabetic nephropathy

1.37

0.37

1.0

1.3

—

Degeneration of macula and posterior pole

0.71

0.37

1.0

1.3

—

Rheumatoid arthritis

1.32

0.37

1.1

1.3

—

Delivery, wide proxy

0.63

0.37

1.4

1.3

—

Other diseases of upper respiratory tract

193

1.16

0.37

1.4

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

202

1.20

0.37

1.5

1.4

—

Reimbursement for rheumatic diseases

151

1.25

0.37

1.3

—

Embedded and impacted teeth

1.40

0.37

1.4

—

Vasomotor and allergic rhinitis

112

0.70

0.37

1.1

1.3

—

Mouth breathing

107

1.31

0.36

1.4

—

Exclusions for E4_PCOS_CONSORTIUM

123

1.22

0.36

1.5

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.35

0.36

1.3

1.4

—

Pacemaker

1.27

0.36

1.2

1.3

—

Abnormalities of heart beat

1.34

0.36

1.0

1.3

—

Other viral diseases, not elsewhere classified

1.26

0.36

1.2

1.4

—

Pre-eclampsia or eclampsia

1.43

0.35

1.2

1.3

—

Other viral diseases, not elsewhere classified

1.42

0.35

1.2

1.4

—

Sulfasalazine

0.62

0.35

1.6

1.4

—

Other and unspecified tonsillitis

1.29

0.35

1.5

—

Maternal care for other conditions predominantly related to pregnancy

1.40

0.35

1.0

1.3

—

Type 2 diabetes

180

1.17

0.35

1.2

1.4

—

Diseases of appendix

220

0.82

0.34

1.1

1.4

—

Spondyloarthritis

1.36

0.34

1.8

1.4

—

Basal cell carcinoma, including avohilmo

1.33

0.34

1.1

1.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

162

1.21

0.34

1.5

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

135

1.25

0.33

1.4

1.3

—

Appendicitis, broad definition

219

0.83

0.32

1.1

1.4

—

Acetic acid derivatives and related substances

0.71

0.32

1.1

1.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

115

1.24

0.32

1.2

1.3

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.33

0.32

1.4

1.3

—

Disorders of skin appendages

137

1.24

0.31

1.5

1.3

—

Type 2 diabetes, definitions combined, including avohilmo

176

1.16

0.31

1.2

1.4

—

Other systemic involvement of connective tissue (FG)

1.35

0.31

1.0

1.4

—

Inguinal hernia

128

1.20

0.31

1.1

1.5

—

Covid-19 suspected case

1.35

0.31

1.0

1.4

—

Subjective visual disturbances

1.35

0.31

1.7

1.3

—

Disorders of lacrimal system

110

1.27

0.31

1.4

1.2

—

Malignant neoplasm of skin

1.29

0.30

1.3

1.4

—

Other systemic involvement of connective tissue

1.30

0.30

1.0

1.3

—

Irregular menses

1.28

0.30

1.3

1.2

—

Iridocyclitis

1.27

0.30

2.0

1.4

—

Dentofacial anomalies [including malocclusion]

175

0.83

0.29

1.3

1.4

—

Gonarthrosis,primary

159

1.16

0.29

1.4

1.3

—

Myocardial infarction, without ST-elevation

1.29

0.29

1.0

1.4

—

Diabetes, insulin treatment (Kela reimbursement)

190

1.14

0.29

1.3

1.4

—

Dental operations

1.19

0.28

1.4

1.3

—

Redundant prepuce, phimosis and paraphimosis

1.32

0.28

1.4

1.5

—

IBD patients in KELA-register

1.25

0.27

1.6

1.5

—

5-aminosalicylic acid

1.25

0.27

1.6

1.5

—

Pre-eclampsia or poor fetal growth

1.25

0.27

1.1

1.3

—

Chronic sinusitis

118

0.76

0.27

1.3

—

Triptan medication for migraine, single purchase ok

168

0.85

0.27

1.4

1.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

168

0.85

0.27

1.4

1.3

—

Inflammatory bowel disease, strict (require KELA)

1.23

0.27

1.6

1.5

—

Soft tissue disorders related to use, overuse and pressure

1.23

0.27

1.0

1.4

—

Ulcerative colitis

1.21

0.26

1.6

1.5

—

Other specified/unspecified arthritis

1.21

0.26

1.4

1.3

—

Other retinal disorders

142

0.82

0.26

1.3

1.4

—

Dental caries, including avohilmo

132

0.85

0.25

1.3

1.4

—

Conjunctivitis (acute, non atopic)

1.29

0.25

1.1

1.3

—

L04AX Other immunosuppressants

160

1.19

0.25

1.2

1.3

—

Disorders of the thyroid gland

183

1.14

0.25

1.2

1.3

—

Migraine

103

0.79

0.25

1.0

1.3

—

Urticaria

1.20

0.25

1.4

1.3

—

Urticaria and erythema

1.25

0.24

1.3

—

Other arthritis (FG)

1.17

0.24

1.3

1.4

—

Varicose veins

100

1.21

0.24

1.3

—

Supervision of normal pregnancy

1.36

0.24

2.0

1.1

—

Statin medication

132

0.85

0.24

1.3

1.4

—

Gonarthrosis, primary, with knee surgery

113

1.20

0.24

1.4

1.3

—

Disorders of tooth development and eruption

1.35

0.23

1.2

1.3

—

Disease of hard tissues of teeth, NOS

0.82

0.23

1.4

1.3

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

1.32

0.23

1.8

1.3

—

Conductive and sensorineural hearing loss

153

1.15

0.23

1.6

1.3

—

Contraceptive management

1.23

0.23

1.4

—

Type 2 diabetes, definitions combined

172

1.13

0.22

1.2

1.4

—

Contact with and exposure to communicable diseases

0.77

0.22

1.0

1.4

—

Pre-eclampsia

1.25

0.22

1.2

1.4

—

Thyrotoxicosis, other and/or unspecified

1.25

0.22

1.0

1.4

—

Psoriasis

1.27

0.22

1.1

1.4

—

Follicular cysts of skin and subcutaneous tissue

1.22

0.22

1.4

1.3

—

Benign neoplasm: Sigmoid colon

1.22

0.22

1.4

1.2

—

Stomatitis and related lesions

1.19

0.21

1.6

1.3

—

Varicella [chickenpox]

0.00

0.21

0.0

1.5

—

Polyhydramnios

0.00

0.21

0.0

1.2

—

Calculus of lower urinary tract

0.00

0.21

0.0

1.0

—

Postmenopausal osteoporosis with pathological fracture

0.00

0.21

0.0

1.3

—

Non-small cell lung cancer, adenocarcinoma

0.00

0.21

0.0

1.0

—

Presbyopia

0.00

0.21

0.0

1.4

—

Other diseases of stomach and duodenum

0.00

0.21

0.0

1.3

—

Corns and callosities

0.00

0.21

0.0

1.5

—

Mandibular retrognathia

0.00

0.21

0.0

1.5

—

Vasomotor rhinitis (mode)

0.00

0.21

0.0

1.2

—

Viral infections of the central nervous system

0.00

0.21

0.0

1.5

—

Other follicular disorders

0.00

0.21

0.0

1.3

—

Endometriosis of rectovaginal septum and vagina

0.00

0.21

0.0

1.1

—

Other contact dermatitis

0.00

0.21

0.0

1.2

—

Glucosamine medication

0.76

0.21

1.4

1.2

—

Struck by thrown, projected or falling objec

0.00

0.21

0.0

1.5

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

0.21

0.0

1.4

—

Thyroiditis

0.00

0.21

0.0

1.3

—

conjunctival haemorrhage

0.00

0.21

0.0

1.2

—

Divergent concomitant strabismus

0.00

0.21

0.0

1.3

—

Other symptoms and signs involving the circulatory and respiratory systems

0.00

0.21

0.0

1.3

—

Varicella [chickenpox]

0.00

0.21

0.0

1.4

—

Congenital malformations of cardiac septa

0.00

0.21

0.0

1.3

—

Inflammatory diseases of female pelvic organs

107

0.82

0.21

1.0

1.3

—

Other disorders of patella

1.16

0.21

1.4

1.5

—

Carcinoma in situ of breast, intraductal

0.00

0.21

0.0

1.4

—

Spontaneous abortion

0.78

0.20

1.0

1.2

—

L02BX Other hormone antagonists and related agents

0.00

0.20

0.0

1.1

—

Contact with other sharp object(s)

0.00

0.20

0.0

1.4

—

Use of galantamine

0.00

0.20

0.0

1.1

—

Deep endometriosis

0.00

0.20

0.0

1.4

—

Infections with a predominantly sexual mode of transmission

110

1.19

0.18

1.1

1.3

—

Thyrotoxicosis

1.13

0.18

1.0

1.4

—

Type 1 diabetes, wide definition, subgroup 1

1.13

0.18

1.2

1.5

—

Other strabismus

1.13

0.18

1.0

1.3

—

Artificial joint operation, meniscal resection

181

1.11

0.18

1.4

—

Noninflammatory disorders of female genital tract

1.23

0.18

1.2

—

Malignant neoplasm of prostate

0.73

0.17

1.4

—

Malignant neoplasm of prostate, including Hilmo

0.71

0.17

1.4

—

Autoimmune diseases related-to ILD

232

1.11

0.17

1.4

1.3

—

malignant neoplasm of male genital organs

0.71

0.17

1.4

—

In situ neoplasms

1.22

0.17

1.0

1.3

—

Glaucoma suspect

1.22

0.17

1.0

1.3

—

Coronary atherosclerosis

111

1.14

0.17

1.5

1.3

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.18

0.16

1.0

1.3

—

Fitting and adjustment of other devices

1.18

0.16

1.5

1.3

—

Second line medication for Crohn's disease

167

1.14

0.16

1.2

1.3

—

Other intervertebral disc disorders

146

1.11

0.16

1.1

1.4

—

Pregnancy hypertension

1.20

0.16

1.1

1.3

—

Triptan medication for migraine, min. 3 purchases

116

0.85

0.16

1.3

—

Gingivitis and periodontal diseases

170

1.09

0.16

1.1

1.4

—

Strabismus

1.11

0.16

1.0

1.3

—

Basal cell carcinoma

1.21

0.15

1.1

1.4

—

Lyme disease

0.79

0.15

1.8

1.3

—

Spirochaetal infections, other/unspecified

0.78

0.15

1.8

1.3

—

Ischaemic heart disease, wide definition

145

1.11

0.15

1.4

1.3

—

Other spirochaetal diseases

0.77

0.15

1.8

1.3

—

Other spirochaetal diseases

0.76

0.15

1.8

1.3

—

Viral and other specified intestinal infections

1.21

0.15

1.1

1.4

—

Type 2 diabetes, strict (exclude DM1)

177

1.09

0.15

1.2

1.4

—

Unstable angina pectoris

1.13

0.15

1.1

1.3

—

Dermatitis and eczema

229

1.08

0.15

1.4

1.3

—

Sulfonylureas

1.10

0.15

1.3

—

Retinal detachments and breaks

1.11

0.15

1.1

1.3

—

Periapical abscess

129

0.85

0.14

1.9

1.4

—

Conjunctivitis

189

1.10

0.14

1.1

1.3

—

Tonsillectomy and adenotomy

124

1.12

0.14

1.4

—

Insomnia

200

1.09

0.14

1.5

1.3

—

Abnormal findings on diagnostic imaging of lung

117

1.15

0.13

1.3

—

Appendectomy

190

1.11

0.13

1.1

1.4

—

Myocardial infarction, strict

1.16

0.13

1.2

1.3

—

Other disorders of eyelid

101

0.85

0.13

1.3

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.16

0.12

1.1

1.3

—

Medical abortion

0.88

0.11

1.4

1.2

—

Diseases of male genital organs

111

0.91

0.11

1.3

1.5

—

Extrapyramidal and movement disorders

1.16

0.11

1.5

1.3

—

Biguanides

190

0.93

0.10

1.3

—

Diabetes medication

200

1.07

0.10

1.3

1.4

—

Hypothyroidism, strict autoimmune

139

1.09

0.10

1.3

—

Rotator cuff syndrome

117

1.10

0.10

1.3

1.4

—

Malignant neoplasm of breast, ER-positive, including Hilmo

1.17

0.10

1.0

1.3

—

Type 2 diabetes, wide definition

154

1.08

0.10

1.2

1.4

—

Psoriasis vulgaris

1.14

0.10

1.2

1.3

—

Acute and subacute iridocyclitis

1.14

0.10

2.2

1.4

—

HSIL lesion of the cervix uteri, vagina or vulva

1.14

0.10

1.0

1.3

—

Dermatitis

173

1.09

0.09

1.1

1.3

—

Shoulder lesions

132

0.92

0.09

1.3

1.4

—

Anterior Iridocyclitis

1.04

0.09

2.2

1.3

—

Acute appendicitis, with complications

1.04

0.09

1.0

1.3

—

Inflammatory bowel disease treatment related agents

217

1.06

0.09

1.2

1.4

—

Diseases of inner ear

131

1.11

0.09

1.1

1.3

—

Maternal care for other known or suspected fetal problems

1.09

0.09

1.0

1.4

—

Other headache syndromes

1.13

0.09

1.1

1.3

—

Allergic asthma (mode)

1.09

0.08

1.2

1.4

—

Coxarthrosis

1.11

0.08

1.4

—

Impacted teeth

1.07

0.08

1.3

1.5

—

Allergic asthma (mode), excluding more controls

1.07

0.08

1.2

1.4

—

Myalgia

1.05

0.08

1.0

1.4

—

Pregnancy, childbirth and the puerperium

0.77

0.08

1.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

132

1.09

0.08

1.2

1.3

—

Diagnoses used for exclusion with ILD

1.03

0.08

1.0

1.2

—

Other and unspecified dermatitis

144

0.90

0.08

1.1

1.3

—

Primary open-angle glaucoma

0.83

0.08

1.0

1.3

—

Major coronary heart disease event excluding revascularizations

110

1.09

0.08

1.2

1.3

—

Allergic conjunctivitis

160

0.91

0.08

1.1

1.3

—

Calcific aortic valvular stenosis

1.06

0.08

1.4

1.3

—

Calcific aortic valvular stenosis, operated

1.06

0.08

1.4

1.3

—

Operations 2 for CAVS

1.06

0.08

1.4

1.3

—

Calcific aortic valvular stenosis, diagnosis (helper)

1.06

0.08

1.4

1.3

—

Calcific aortic valvular stenosis, including rheumatic fever

1.06

0.08

1.4

1.3

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

176

1.06

0.08

1.3

1.4

—

Endometriosis

0.84

0.08

1.2

—

Myocardial infarction

1.11

0.08

1.2

1.3

—

Type 1 diabetes

1.03

0.07

1.1

1.4

—

Sleep disorders (combined)

210

1.05

0.07

1.4

1.3

—

Medicines for HER+ breast cancer

0.85

0.07

1.0

1.3

—

Benign lipomatous neoplasm

0.83

0.07

1.3

1.4

—

Other enthesopathies

0.82

0.07

1.3

1.4

—

Sub-endpoint used in defining T1D endpoints

1.06

0.07

1.1

1.4

—

Other abnormal products of conception

0.87

0.07

1.1

1.3

—

Other benign neoplasms of skin

0.82

0.07

1.1

1.3

—

Diabetic retinopathy

0.86

0.07

1.0

1.3

—

Caries of dentine, including avohilmo

141

0.94

0.07

1.2

1.4

—

0.88

0.06

1.1

1.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

111

0.90

0.06

1.6

1.4

—

Diseases of pulp and periapical tissues and dental caries

115

0.94

0.06

1.3

—

Caries of enamel

213

1.05

0.06

1.2

1.4

—

Chronic diseases of tonsils and adenoids

168

1.05

0.05

1.3

—

Persons encountering health services in circumstances related to reproduction

116

0.93

0.05

1.3

1.4

—

Rheumatoid arthritis, including avohilmo

1.11

0.05

1.1

1.3

—

Oral corticosteroids

212

1.04

0.04

1.2

1.4

—

Hyperplasia of prostate

1.07

0.03

1.0

1.4

—

Coxarthrosis, primary, with hip surgery

104

1.08

0.03

1.4

1.3

—

Acute sinusitis

149

1.06

0.03

1.2

1.3

—

Other (not insulin) diabetes medications

184

0.97

0.03

1.3

—

Complications of labour and delivery

0.94

0.02

1.4

1.2

—

Glaucoma

122

1.06

0.02

1.1

1.3

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

153

0.95

0.02

1.1

1.3

—

Excessive attrition of teeth

166

0.96

0.00

1.4

—

Genitourinary diseases

107

1.03

0.00

1.3

1.5

—

Coxarthrosis, primary

132

0.96

0.00

1.5

1.3

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

152

1.02

0.00

1.4

1.3

—

Sleep apnoea

198

1.01

0.00

1.3

1.4

—

Pregnancy with abortive outcome

0.97

0.00

1.1

1.2

—

Disorders of conjunctiva

205

1.02

0.00

1.1

1.4

—

Sleep disorders

208

1.01

0.00

1.6

1.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

100

1.00

0.00

1.4

1.3

—

Noninfective enteritis and colitis

132

0.98

0.00

1.4

—

Behavioural syndromes associated with physiological disturbances and physical factors

213

1.00

0.00

1.5

1.3

—

Antihypertensive medication - note that there are other indications

103

1.03

0.00

1.4

—

Papulosquamous disorders

105

1.05

0.00

1.1

1.4

—

Coxarthrosis [arthrosis of hip](FG)

0.99

0.00

1.4

1.3

—

Presence of other functional implants

0.99

0.00

1.5

1.3

—

Disorders of eyelid, lacrimal system and orbit

190

1.00

0.00

1.4

1.3

—

Sensorineural hearing loss

147

1.02

0.00

1.7

1.3

—

Dermatophytosis

196

1.02

0.00

1.4

—

Inflammatory bowel disease

1.04

0.00

1.5

1.4

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

162

1.00

0.00

1.3

—

Sleep apnoea, including avohilmo

204

1.00

0.00

1.3

1.4

—

Other maternal disorders predominantly related to pregnancy

1.01

0.00

1.2

1.3

—

Atopic dermatitis

153

1.02

0.00

1.6

1.4

—

Disorders of vestibular function (Vertigo)

111

0.97

0.00

1.0

1.3

—

Other Crohn's disease

0.00

0.0

1.6

—

Nonspecific lymphadenitis

0.00

0.0

1.5

—

Osteoporosis

0.99

0.00

1.0

1.2

—

Other salmonella infections

0.00

0.0

1.4

—

Temporal arteritis

0.00

0.0

1.0

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.0

1.6

—

Giant cell arteritis with polymyalgia rheumatica

0.00

0.0

1.0

—

Non-Hodgkin lymphoma, all

0.00

0.0

1.0

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

0.00

0.0

1.8

—

Complications predominantly related to the puerperium

0.86

0.00

1.0

1.3

—

Bicuspidal aortic valve syndrome

0.00

0.0

1.4

—

Other obstructive and reflux uropathy

0.00

0.0

1.3

—

Left ventricular outflow tract obstruction, narrow definition

0.00

0.0

1.4

—

Type 1 diabetes, wide definition

1.02

0.00

1.2

1.5

—

Distal bite

0.00

0.0

1.4

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

-0.00

0.0

1.4

—

Other extrapyramidal and movement disorders in other diseases

0.93

-0.00

1.4

1.2

—

Viral and other specified intestinal infections

0.94

-0.00

1.0

1.4

—

Ankylosing spondylitis, strict definition

0.00

-0.00

0.0

1.6

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

0.00

-0.00

0.0

1.4

—

Benign neoplasm of urinary organs

0.00

-0.00

0.0

1.0

—

Ulcerative proctitis

0.00

-0.00

0.0

1.7

—

Prolapse and hernia of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

Crohn disease (strict definition, require KELA)

0.00

-0.00

0.0

1.6

—

Acute alcohol intoxication ICD-9

0.00

-0.00

0.0

1.4

—

Melanocytic naevi

0.96

-0.00

1.4

1.3

—

Unknown and unspecified causes of morbidity

0.00

-0.00

0.0

1.7

—

Juvenile arthritis (FINNGEN)

0.00

-0.00

0.0

1.7

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.00

-0.00

0.0

1.0

—

Crohn's disease of large intestine

0.00

-0.00

0.0

1.7

—

Tinnitus

0.86

-0.00

1.0

1.2

—

Diffuse large B-cell lymphoma

0.00

-0.00

0.0

1.0

—

Non-small cell lung cancer, squamous

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of larynx, including Hilmo

0.00

-0.00

0.0

1.0

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.91

-0.00

1.0

1.3

—

Gestational [pregnancy-induced] hypertension

0.88

-0.00

1.0

1.3

—

Chronic tubulo-interstitial nephritis

0.00

-0.00

0.0

1.4

—

Other and unspecified effects of external causes

1.00

-0.00

1.0

1.3

—

Hypogonadotropic hypogonadism

0.00

-0.00

0.0

1.6

—

Giant cell arteritis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Choroid

0.00

-0.00

0.0

1.2

—

Unspecified abortion

0.00

-0.00

0.0

1.4

—

Dysplasia of cervi uteri

0.98

-0.00

1.0

1.2

—

Generalized skin eruption due to drugs and medicaments

0.00

-0.00

0.0

1.0

—

Seropositive rheumatoid arthritis, wide

0.93

-0.00

1.0

1.2

—

Optic neuritis

0.00

-0.00

0.0

1.7

—

Other disorders of prostate

0.00

-0.00

0.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.92

-0.00

1.3

1.4

—

Ingrowing nail

0.00

-0.00

0.0

1.3

—

Skin changes due to chronic exposure to nonionizing radiation

0.96

-0.00

1.1

1.3

—

Actinic keratosis

0.88

-0.00

1.0

1.3

—

Other ulcerative colitis

0.00

-0.00

0.0

1.6

—

Dermatitis due to substances taken internally

0.00

-0.00

0.0

1.0

—

Crohn disease (strict definition, all UC cases excluded)

0.00

-0.00

0.0

1.7

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.98

-0.00

1.0

1.2

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

1.3

—

Other/unspecified seropositive rheumatoid arthritis

0.94

-0.00

1.0

1.2

—

Other abnormal findings of blood chemistry

0.00

-0.00

0.0

1.3

—

Voice disturbances

0.94

-0.00

1.6

1.3

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

-0.00

0.0

1.0

—

Seropositive rheumatoid arthritis

1.00

-0.00

1.0

1.3

—

Atopic conjunctivitis

0.00

-0.00

0.0

1.8

—

Non-small cell lung cancer, squamous, helper endpoint

0.00

-0.00

0.0

1.0

—

Contusion of other and unspecified parts of foot

0.00

-0.00

0.0

1.7

—

Disturbances of smell and taste

0.00

-0.00

0.0

1.3

—

Burn and corrosion of wrist and hand

0.00

-0.00

0.0

1.6

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.92

-0.00

1.0

1.4

—

Chorioretinal inflammation

0.00

-0.00

0.0

1.8

—

Diffuse large B-cell lymphoma, helper endpoint

0.00

-0.00

0.0

1.0

—

Diffuse large B-cell lymphoma, including Hilmo

0.00

-0.00

0.0

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.93

-0.00

1.6

1.4

—

Cramp and spasm

0.00

-0.00

0.0

1.6

—

Intermittent heterotropia

0.00

-0.00

0.0

1.3

—

Habit and impulse disorders

0.00

-0.00

0.0

2.0

—

Glucagon-like peptide-1 (GLP-1) analogues

0.92

-0.00

1.3

1.4

—

Desensitization to allergens

0.00

-0.00

0.0

1.3

—

Examination and encounter for administrative purposes

0.00

-0.00

0.0

1.3

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

-0.00

0.0

1.6

—

Other disorders of adrenal gland

0.00

-0.00

0.0

1.4

—

Congenital malformations of aortic and mitral valves

0.00

-0.00

0.0

1.5

—

Other benign neoplasms of uterus

0.00

-0.00

0.0

1.2

—

Use of biperiden

0.00

-0.00

0.0

1.6

—

Melanocytic naevi of other and unspecified parts of face

0.00

-0.00

0.0

1.3

—

Immunodeficiency with predominantly antibody defects

0.00

-0.00

0.0

1.4

—

Other noninflammatory disorders of cervix uteri

0.00

-0.00

0.0

1.1

—

Immunodeficiencies

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Kidney

0.00

-0.00

0.0

1.0

—

Deviated nasal septum

0.93

-0.00

1.2

1.4

—

All dysplastic lesions of the cervix uteri

0.92

-0.00

1.0

1.3

—

Complications following abortion and ectopic and molar pregnancy

0.00

-0.00

0.0

1.3

—

Other and unspecified injuries of ankle and foot

0.00

-0.00

0.0

1.7

—

Malignant neoplasm, without specification of site

0.00

-0.00

0.0

1.0

—

Bullous disorders

0.00

-0.00

0.0

1.3

—

Benign paroxysmal vertigo

1.02

-0.00

1.0

1.3

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.6

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Tobacco use

0.00

-0.00

0.0

1.6

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

-0.00

0.0

1.0

—

Septal defects

0.00

-0.00

0.0

1.5

—

Migraine with aura

0.98

-0.00

1.0

1.3

—

Other noninfective gastroenteritis and colitis

0.85

-0.00

1.2

1.3

—

Renal cell carcinoma of kidney

0.00

-0.00

0.0

1.0

—

Laparoscopic right hemicolectomy

0.00

-0.00

0.0

1.0

—

Enthesopathies of lower limb, excluding foot

0.98

-0.00

1.0

1.5

—

Malignant neoplasm, without specification of site, including Hilmo

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Intrinsic coagulation system thromboelastography panel - Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS